ABSTRACT
INTRODuCTION
Myocardial bridging (MB) is defined as a congenital coronary anomaly, 1 represented by a segment of a major epicardial coronary artery that proceeds intramurally through the myocardium, beneath the muscle bridge.
MB can cause variable degrees of systolic compression. It was first described in 1737 by Reyman during an autopsy. 2 Portman and Iwing reported the first case of MB detected by tomography coronary angiography. 3 Because it is a "silent" condition which may be associated with severe ischemia caused by the systolic compression of the coronary artery, MB is a subject frequently debated in the literature. The prevalence of MB is still unknown, although from autopsy studies its reported as being present in 25-85% of the patients. 4 Diagnostic imaging methods such as angiography suggest that the incidence of MB ranges from 0.8% to 4.9%. 5 Non-invasive procedures tend to be more frequently used by clinicians in diagnosing the etiology of coronary artery disease, due to their high specificity. Moreover, many patients accept these procedures as they are not invasive and can be performed ambulatory. 
MATERIALS AND METHODS
Fifty-nine patients presenting at the emergency department from January 2015 -September 2015 for typical angina and an ECG diagnosis of myocardial ischemia who were subsequently referred for 64-Slice Computed Tomography Angiography were enrolled in the study. None of the patients underwent percutaneous coronary angioplasty at that visit, nor presented a history of coronary angioplasty. All patients were subjected to blood sampling and MSCTA. According to the radiological protocol for lowering the heart rate, Metoprolol was administered to maintain the heart rate at under sixty beats per minute.
An intravenous line was inserted into the right antecubital vein for contrast administration. The study has been carried out in accordance with the code of ethics of the World Medical Association's Declaration of Helsinki. All patients gave written informed consent, and the study protocol was approved by the ethics committee of the Cardio Med Medical Center, the center where the study was conducted.
Sub-Study for Ct analySiS of Mb
In the CT analysis sub-study 30 patients with muscular bridging on whom MSCTA reconstructions of the ventricular cavities had been carried out, were enrolled. This non-invasive procedure consisted in the measurement of the thickness of the ventricular walls and the detection of thinned areas, which showed ischemia and contractility dysfunction. The left ventricle was divided into seventeen segments for regional analysis of left ventricular function or myocardial perfusion according to AHA (Figure 1) . 9 The area with contractility dysfunction is shown 
RESuLTS
The mean age of patients with MB was 55.51 ± 11.4 years, CI 51.57-59.45 years; patients without MB had a mean age of 59.17 ± 9.6 years, CI 54.98-63.6 years.
24.32% of patients with MB were females, while 60.86%
without MB were males (p = 0.04). 
Ct SubStudy reSultS
CT characteristics of the population enrolled in the substudy are presented in Table 1 .
The mean length of the muscular bridging was 2.194 ± 0.914 cm. (Table 2) .
DISCuSSIONS
In this study, the presence of muscular bridging was much 
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CONCLuSIONS
There is a good positive correlation between the location of the MB and the ischemic segments showing on polar maps as thinned areas colored in blue, purple spots. Also, the 3D Polar Mapping procedure can be useful for identification of a correlation between the location of ischemic segments and the ECG location of ischemia. 
